Irbesartan And Hydrochlorothiazide
Product Images NDC 70518-3593

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 70518-3593). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 1a (22bf08c2 615b 4b48 Af36 1b71a91459dc 01)

A line graph displaying baseline systolic blood pressure (SBP) in mmHg on the x-axis versus the percentage of subjects with SBP below 140 mmHg on the y-axis. Multiple lines represent different studies and drug groups, including average and irbesartan groups for Studies V and VI, and an HCTZ Study V group. The chart compares blood pressure outcomes across these study arms.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 1b (22bf08c2 615b 4b48 Af36 1b71a91459dc 02)

A line graph showing the percentage of subjects with systolic blood pressure (SBP) under 130 mmHg on the vertical axis against baseline SBP in mmHg on the horizontal axis. The graph compares results across different studies labeled as Av., Irb., HCTZ, and Av. Study VI.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 2a (22bf08c2 615b 4b48 Af36 1b71a91459dc 03)

A line graph presenting the percent change in diastolic blood pressure (DBP) from baseline versus baseline DBP (mmHg). Multiple lines represent data from different studies labeled as Study V and Study VI, including groups for Irbesartan, Hydrochlorothiazide, and average study results. The vertical axis shows percent DBP change, and the horizontal axis shows baseline DBP values from 90 to 130 mmHg.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 2b (22bf08c2 615b 4b48 Af36 1b71a91459dc 04)

A line graph depicting the percentage reduction of diastolic blood pressure (DBP) below 80 mmHg across different baseline DBP values from 90 to 130 mmHg. The graph includes multiple lines representing average and individual study data for Irbesartan and Hydrochlorothiazide treatments from Study V and Study VI.*

FDA Label Image

Chemical Structure Irbesartan (22bf08c2 615b 4b48 Af36 1b71a91459dc 05)

Chemical structure of the active ingredients in Irbesartan and Hydrochlorothiazide, showing the molecular arrangement with various rings and nitrogen atoms depicted.*

FDA Label Image

Chemical Structure Hydrochlorothiazide (22bf08c2 615b 4b48 Af36 1b71a91459dc 06)

Chemical structure of irbesartan, an active ingredient in the combination product Irbesartan and Hydrochlorothiazide from REMEDYREPACK INC. The structure shows the molecular arrangement including ring systems, chlorine, sulfonamide, and other functional groups.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 3 (22bf08c2 615b 4b48 Af36 1b71a91459dc 07)

A scatter plot with a curve showing the relationship between irbesartan dose in mg/day (x-axis) and placebo-subtracted reduction in trough SeSBP in mmHg (y-axis). Data points show individual values and a fitted line represents the trend of blood pressure reduction with increasing dose.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 4 (22bf08c2 615b 4b48 Af36 1b71a91459dc 08)

A scatter plot with a fitted curve showing the placebo-subtracted reduction in trough SeDBP (systolic blood pressure) as a function of Irbesartan dose in mg/day. The x-axis represents Irbesartan dose ranging from 0 to 900 mg/day, and the y-axis represents the reduction in mmHg.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Irbesartan / HCTZ 150 mg / 12.5 mg tablets, repackaged by RemedyRepack Inc. The label states a quantity of 90 tablets and includes usage and storage instructions referencing the package insert. The manufacturer is Solco, based in Cranbury, NJ, and the product NDC is 70518-3593-00.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.